Skip to main content
. 2023 May 22;5(3):dlad060. doi: 10.1093/jacamr/dlad060

Table 2.

AMR patterns of Escherichia coli isolates (n = 365)

Antibiotic name % R % I % S % R 95%CI
Amoxicillin/Clavulanic acid 25 (7.4) 32 (9.4) 282 (83.2) 13.1–21.3
Ampicillin 183 (54.0) 40 (11.8) 116 (34.2) 48.5–59.4
Cefotaxime 103 (30.4) 39 (11.5) 197 (58.1) 25.6–35.6
Ceftazidime 21 (6.2) 29 (8.6) 289 (85.3) 4.0–9.5
Cefepime 21 (6.2) 61 (18.0) 257 (75.8) 4.0–9.5
Chloramphenicol 30 (8.8) 18 (5.3) 291 (85.8) 6.1–12.5
Ciprofloxacin 86 (25.4) 80 (23.6) 173 (51.0) 20.9–30.4
Gentamicin 29 (8.6) 69 (20.4) 241 (71.1) 5.9–12.2
Meropenem 3 (0.9) 15 (4.4) 321 (94.7) 0.2–2.8
Nitrofurantoin 41 (12.1) 72 (21.2) 226 (66.7) 8.9–16.2
Tetracycline 184 (54.3) 52 (15.3) 103 (30.4) 49.1–59.9
Trimethoprim/Sulfamethoxazole 90 (26.5) 12 (3.5) 237 (69.9) 22.0–31.6
Nalidixic acid 82 (24.2) 58 (17.1) 199 (58.7) 19.8–29.2

Note. R = Resistant, I = Intermediate, S = Susceptible, 95% CI = 95% confidence interval.